The apoptosis mechanisms of HepG2 cells induced by bitter melon seed
Qing-Guo Cao1, Qin Guo2, Jie Bai2
1Department of College of Tea and Food Science and Technology, Jiangsu Vocational College of Agriculture and Forestry, Zhenjiang, China.
Abstract:
Liver cancer is one of the leading causes of cancer-related deaths in the world. Bitter melon seed (BMS) is well known for anti-inflammatory and anticancer properties. MicroRNA-421 (miR-421) is considered as a regulator of cancer initiation, tumor metastasis, and progression, interfering with transcription of the mRNAs responsible for the cancer pathogenesis. HepG2 cells were treated with BMS water extract (BMSW) for 24 hr, and the IC50 was 586.27 ± 0.07 µg/ml. The ROS, mitochondrial membrane potential, the protein expression, and the nuclear fragmentation after the treatment of BMSW were respectively detected. The increase of ROS resulted in the decrease of mitochondrial membrane potential, which induced the apoptosis of cells subsequently. BMSW inhibited the proliferation of HepG2 cells by blocking cell cycle in the S phase and influenced the nuclei and the expression of protein, leading to cellular laxity and apoptosis. The expression level of miR-421 in HepG2 was distinctly down-regulated by 13.74 fold with 600 µg/ml of BMSW. Comprehensive microarray and RT-PCR analysis identified six putative target genes of miR-421 (GADD45B, DUSP6, DUSP3, DUSP10, CASP3, and CAPN2). The relationships of DUSP6, CASP3, and miR-421 were further confirmed by miR-421 mimics/inhibitor transfection by RT-PCR and western blot. The CASP3 was identified as target gene of miR-421. BMSW induced the apoptosis of HepG2 cell by regulating miR-421 and CASP3. PRACTICAL APPLICATIONS: Hepatocellular carcinoma (HCC) is a malignant tumour with the fourth highest mortality rate in the world. Bitter melon seed (BMS) as edible and medical food has significant anticancer activity. Our study indicated the anticancer mechanisms of BMS and provided the scientific basis for the application of BMS in healthy or novel functional foods. BMS can be used as dietary supplements or nutritional fortifiers to improve the survival status of patients with liver cancer due to safety and effectiveness.
Insights
Bitter melon seed extract (BMSW) induces liver cancer cell apoptosis by regulating microRNA-421 (miR-421) and CASP3. This study provides a scientific basis for using BMS as a dietary supplement for liver cancer patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Liver cancer is a leading cause of cancer-related mortality globally.
- Bitter melon seed (BMS) possesses known anti-inflammatory and anticancer properties.
- MicroRNA-421 (miR-421) plays a role in regulating cancer initiation, metastasis, and progression.
Purpose of the Study:
- To investigate the anticancer mechanisms of bitter melon seed water extract (BMSW) on HepG2 liver cancer cells.
- To elucidate the role of miR-421 and its target genes in BMSW-induced apoptosis.
Main Methods:
- HepG2 cells were treated with BMSW, and cell viability (IC50) was determined.
- Assays were conducted to measure reactive oxygen species (ROS), mitochondrial membrane potential, protein expression, and nuclear fragmentation.
- Microarray, RT-PCR, and western blot analyses were used to assess miR-421 expression and its target genes, including CASP3.
Main Results:
- BMSW treatment led to increased ROS, decreased mitochondrial membrane potential, and induced apoptosis in HepG2 cells.
- BMSW inhibited HepG2 cell proliferation by blocking the cell cycle in the S phase.
- BMSW significantly down-regulated miR-421 expression, identifying CASP3 as a direct target gene, and promoting apoptosis.
Conclusions:
- BMSW effectively induces apoptosis in HepG2 liver cancer cells through the regulation of miR-421 and CASP3.
- The findings support the potential of BMS as a dietary supplement or functional food for improving outcomes in liver cancer patients.
- This study provides a scientific foundation for the therapeutic application of bitter melon seed in managing hepatocellular carcinoma.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...


